Collectively, Tregs overexpressing Viperin displayed a phenotype consistent with that observed in ITP patient-derived Tregs, indicating that Viperin may act as a key regulator of Treg instability in ITP and may represent a potential therapeutic target. Here, RSAD2 is linked to autoimmune thrombocytopenic purpura.